Northern Trust’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Buy
21,826
+3,836
+21% +$32.8K ﹤0.01% 3919
2026
Q1
$98.8K Hold
17,990
– – ﹤0.01% 4110
2025
Q4
$475K Buy
17,990
+16,770
+1,375% +$324K ﹤0.01% 3674
2025
Q3
$23.3K Hold
1,220
– – ﹤0.01% 4359
2025
Q2
$23.7K Sell
1,220
-14,888
-92% -$289K ﹤0.01% 4323
2025
Q1
$230K Sell
16,108
-924
-5% -$17.7K ﹤0.01% 3895
2024
Q4
$421K Sell
17,032
-789
-4% -$22K ﹤0.01% 3715
2024
Q3
$541K Buy
17,821
+16,387
+1,143% +$642K ﹤0.01% 3563
2024
Q2
$73.5K Buy
1,434
+214
+18% +$16.5K ﹤0.01% 4123
2024
Q1
$108K Buy
+1,220
New +$123K ﹤0.01% 4057

Other funds holding GUTS

Northern Trust's GUTS Position: Q2 2026 in Review

Northern Trust increased its Fractyl Health (GUTS) stake by 21% in Q2 2026, buying an estimated $32.8K and bringing the position to 21,826 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

Northern Trust first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $541K in Q3 2024. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Northern Trust held 21,826 shares of Fractyl Health worth $208K as of Q2 2026.
  • Northern Trust bought 3,836 Fractyl Health shares in Q2 2026, an estimated $32.8K.
  • Fractyl Health made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3919 holding.
  • Northern Trust first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Northern Trust's Fractyl Health position peaked at $541K in Q3 2024.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.